MAPT and Alzheimer disease: Most dominant neuropathological changes observed in AD are senile plaques, which are deposits of amyloid β protein (Aβ42) in the brain parenchyma and blood vessel walls, along with cerebral amyloid angiopathy (CAA) and neurofibrillary pathology due to hyperphosphorylation of tau protein [28,55].